FEG
OGN icon

Financial Enhancement Group’s Organon & Co OGN Stock Holding History

Financial Enhancement Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-440
Closed -$10K – 251
2022
Q3 		$10K Hold
440
– – ﹤0.01% 191
2022
Q2 		$15K Hold
440
– – ﹤0.01% 175
2022
Q1 		$15K Hold
440
– – ﹤0.01% 177
2021
Q4 		$13K Hold
440
– – ﹤0.01% 185
2021
Q3 		$14K Buy
440
+400
+1,000% +$12.8K ﹤0.01% 184
2021
Q2 		$1K Buy
+40
New +$1.32K ﹤0.01% 258

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Financial Enhancement Group's OGN Position: Q4 2022 in Review

Financial Enhancement Group sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 440 shares — an estimated $10K sold.

Financial Enhancement Group first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $15K in Q2 2022. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Financial Enhancement Group reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Financial Enhancement Group sold 440 Organon & Co shares in Q4 2022, an estimated $10K.
  • Financial Enhancement Group first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Financial Enhancement Group's Organon & Co position peaked at $15K in Q2 2022.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.